PRESS-RELEASE ·Filed Jul 14, 2026

ERAS

Erasca, Inc.
BEARISH
Impact 7/10
Horizonimmediate Processed2mo ago WireGlobeNewswire
Press release: offering
Actionable Insight ▼ Bearish

The rapid pricing and significant dilution suggest Erasca needed cash urgently, possibly ahead of a material R&D milestone or to extend runway into a binary catalyst. Traders should watch for any pipeline updates (data readouts, IND filings) in the coming weeks that could explain the timing. The large raise at near-market (no discount disclosed) partly mitigates the bearish signal, but the ~20% dilution is meaningful. Monitor secondary trading for stabilization after the July 15 close.

DirectionBearish
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
ERAS ▼ -6.10% at T+20d
SHORT call ✓ call won +6.10% · α vs SPY +8.59% · entry $19.50 → $18.31
Next anchor: T+60d in 4d
Latest observation: T+55 -4.11% FF3 residual α
Entry anchored
Jul 13, 04:33 PM ET
via exchange tick
T+1d
+9.03%
call -9.03% · α -8.63%
$21.26
settled 3mo ago
T+5d
-3.49%
call +3.49% · α +2.19%
$18.82
settled 2mo ago
T+20d
-6.10%
call +6.10% · α +8.59%
$18.31
settled 8w ago
T+60d
—
call — · α —
—
in 4d

Price Chart

Loading chart...

Executive Summary

Erasca has priced an upsized public offering of 31,428,572 shares at $17.50/share, expecting ~$550M in gross proceeds. The offering represents significant dilution (roughly 20% of pre-offer shares) and closed the same day the S-3 was filed, suggesting urgency to raise capital. Given the company's $5.8B market cap and the large raise, this is a material event that signals either aggressive pipeline funding or potential near-term cash needs.

Key Financial Metrics

Deal Value
$550.0M

Key Facts

  • 31,428,572 shares offered at $17.50/share
  • Expected gross proceeds of approximately $550.0 million
  • Underwriters have a 30-day option for up to an additional 4,714,285 shares
  • S-3 shelf registration filed and became effective on July 13, 2026 (same day as pricing)
  • Joint book-runners: J.P. Morgan, Morgan Stanley, Jefferies, Evercore ISI
  • Offering expected to close July 15, 2026
  • Proceeds to fund R&D of product candidates and for working capital

Financial Impact

Approximately $550M in gross proceeds from issuance of ~31.4M new shares. Based on pre-offer share count (implied from market cap / price), dilution is roughly 20%.

dilutioncashPositionworkingCapital

Risk Factors

  • Significant dilution (~20%) to existing shareholders
  • Offering size was upsized, suggesting strong demand but also larger capital needs
  • Proceeds use is vague ('research and development' and 'working capital'), raising uncertainty about specific deployment
  • The S-3 and pricing occurred the same day, indicating a pre-planned accelerated offering

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (17 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3326554
21 reports for ERAS
Performance horizon
88% Hit rate 7 of 8 directional calls best @ T+60▲ +95.35%Apr 27, 2026
Filters
Rows
Reports for ERAS — sortable, filterable
TypeNow
Aug 24, 2026
5w ago
8-K
BULLISH ★ 5/10
$17.60 $15.55▼ −11.65%▼ −12.96%$14.94 (−15.09%)
Aug 17, 2026
6w ago
144
NEUTRAL ★ 3/10
$18.28 $16.16▼ −11.60%▼ −10.07%$14.94 (−18.24%)
Aug 13, 2026
7w ago
Institutional Cluster
BULLISH ★ 6/10
$17.86 $15.88▼ −11.09%▼ −9.34%$14.94 (−16.32%)
Aug 12, 2026
7w ago
3
NEUTRAL ★ 2/10
$17.86 $15.88▼ −11.09%▼ −9.34%$14.94 (−16.32%)
Aug 11, 2026
7w ago
Press Release
NEUTRAL ★ 5/10
$18.58 $16.03▼ −13.72%▼ −11.83%$14.94 (−19.56%)
Jul 22, 2026
10w ago
Press Release
BEARISH ★ 6/10
$19.51 $18.07▲ +7.38%▲ +10.28%$14.94 (+23.40%)
Jul 14, 2026
11w ago
8-K
MIXED ★ 6/10
$21.26 $18.58▼ −12.61%▼ −14.95%$14.94 (−29.70%)
Jul 14, 2026
11w ago
424B5
MIXED ★ 6/10
$21.26 $18.58▼ −12.61%▼ −14.95%$14.94 (−29.70%)
Jul 14, 2026
11w ago
Press Release
BEARISH ★ 7/10
$19.50 $18.31▲ +6.10%▲ +8.59%$14.94 (+23.36%)
Jul 13, 2026
11w ago
Press Release
BULLISH ★ 7/10
$19.50 $18.31▼ −6.10%▼ −8.59%$14.94 (−23.36%)
Showing 10 of 21

US Market Status

Market Open — Closes in 3h 55m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 14, 2026